Safety and Acceptability of the Anti-Microbe Vaginal Gel, PMPA Gel
Status:
Completed
Trial end date:
2005-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the PMPA gel, which kills microbes, in HIV-infected
and HIV-uninfected women.
The majority of new HIV infections occur through heterosexual contact. A product that stops
or slows the replication of HIV during sexual contact is needed. At present, there are no
products that are completely effective. PMPA gel, also known as tenofovir, is an anti-microbe
agent that may fight against sexual transmission of HIV and other sexually transmitted
diseases (STDs). It is applied to the vagina and gives women the ability to control their
disease-prevention activity.
Phase:
Phase 1
Details
Lead Sponsor:
National Institute of Allergy and Infectious Diseases (NIAID)